News
AMR is one of the most urgent public health challenges facing the world today. Drug-resistant infections make illnesses harder to treat, increase healthcare costs, prolong hospital stays, and contribute to preventable deaths.
Swipe for more stories
-
bioMérieux Joins MALDIBANK: Advancing the Future of Microbial Identification Through AI and Collaboration
At bioMérieux, we have a long-standing commitment to advancing microbial identification and helping laboratories make faster, more confident decisions. We are pleased to participate in MALDIBANK, an ambitious European Union-funded initiative designed to accelerate innovation in microbial identification through the integration of MALDI-TOF Mass Spectrometry, artificial intelligence, and cloud-based data infrastructure. -
Respiratory Infections: Supporting Better Health Decisions Through Diagnostics
Respiratory infections remain a significant challenge for patients, healthcare professionals, and healthcare systems worldwide. From seasonal respiratory illnesses to more severe infections, clinicians often face complex decisions when evaluating patients whose similar symptoms can have many possible causes. -
bioMérieux receives Dual 510(k) Clearance and CLIA Waiver from the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel to Advance Women’s Health with Rapid Molecular Diagnostics
bioMérieux's BIOFIRE® SPOTFIRE® Vaginitis (VG) Panel has received Dual 510(k) Clearance and CLIA Waiver* from the U.S. Food and Drug Administration (FDA).
Enabling Decision-Making
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19
- ANTIMICROBIAL STEWARDSHIP
- SEPSIS
- FOOD SAFETY & QUALITY
- PHARMA QUALITY CONTROL
- COVID-19